Literature DB >> 19081249

Synthesis of 10-substituted triazolyl artemisinins possessing anticancer activity via Huisgen 1,3-dipolar cylcoaddition.

Sungsik Cho1, Sangtae Oh, Yumi Um, Ji-Hee Jung, Jungyeob Ham, Woon-Seob Shin, Seokjoon Lee.   

Abstract

Most of the 10-substituted triazolylartemisinin synthesized via the Huisgen 1,3-dipolar cylcoaddition of diastereomeric 10-azidoartemisinin (5, 6, and 7) with various alkynes (a-h) exhibit strong growth inhibition activity, even at sub-micromolar concentrations, against various cancer cell lines such as DLD-1, U-87, Hela, SiHa, A172, and B16. In particular, 10b and 10f showed a highly strong cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081249     DOI: 10.1016/j.bmcl.2008.11.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

2.  LC-UV/MS quality analytics of paediatric artemether formulations.

Authors:  Kirsten Vandercruyssen; Matthias D'Hondt; Valentijn Vergote; Herwig Jansen; Christian Burvenich; Bart De Spiegeleer
Journal:  J Pharm Anal       Date:  2013-04-25

3.  Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin.

Authors:  Gab-Man Park; Hyun Park; Sangtae Oh; Seokjoon Lee
Journal:  Korean J Parasitol       Date:  2017-12-31       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.